Immunotherapy for bowel cancer could change clinical practice

A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the ‘progression free survival’ time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy. ‘Progression free survival’ is the length of time during and…

Details

Growing evidence that minority ethnic groups in England may be at higher risk of COVID-19

Previous pandemics have often disproportionately impacted ethnic minorities and socioeconomically disadvantaged populations. While early evidence suggests that the same may be occurring in the current SARS-CoV-2 pandemic, research into the subject remains limited. A team of researchers at the University of Glasgow and Public Health Scotland, UK analysed data on 392,116 participants in the UK…

Details

Rediscovering Wine After Covid-19

This is a story about what happens when one of life’s joys is taken away, perhaps forever. In this case it’s wine, but it could as easily have been painting, cooking, dancing, or playing golf or tennis. The potential loss of these pleasures, of course, is trivial compared with the social and personal catastrophes the…

Details